Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Karim Dip-Borunda"'
Autor:
Rocio Grajales-Alvarez, Alicia Gutiérrez-Mata, Christian Pichardo-Piña, Marcos Gutiérrez-De la Barrera, Karim Dip-Borunda
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEThe Instituto Mexicano del Seguro Social is a tripartite contribution providing care to more than 74 million beneficiaries, representing more than 50% of the country's general population. This study aims to describe the survival outcomes and c
Externí odkaz:
https://doaj.org/article/e79ec1454ea74e88b0051dd9ac17b315
Autor:
Abdel Karim Dip Borunda, Ricardo Jesus Arteaga Garcia, Javier Barragan Los Santos, Rafael Medrano Guzman, Alvaro Leal Sosa, Alfonso Pimentel
Publikováno v:
Journal of Clinical Oncology. 41:524-524
524 Background: Gallbladder and other biliary tract tumors account for 0.6 % of all cancers. There is scarce data of Ampullary cancers, but it is known as an extremely rare neoplasia accounting just for 0.2% of gastrointestinal cancers and 7% of peri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad4b64273e95c01c1f639d50be14ff3f
https://doi.org/10.1200/jco.2023.41.4_suppl.524
https://doi.org/10.1200/jco.2023.41.4_suppl.524
Autor:
Abdel Karim Dip Borunda, Alberto Pimentel Renteria, Rocío Grajales Álvarez, Miguel Pluma Jiménez, Mario Pérez Martínez, Juan Alejandro Silva, Yolanda Bautista Aragón, Miguel Quintana, Gloria Martinez Martinez, Samuel Rivera Rivera
Publikováno v:
Journal of Gastrointestinal Oncology. 7:632-637
Background: Stromal tumors of the digestive tract are uncommon malignant diseases, are subclassified as leiomyosarcomas and Gastrointestinal Stromal Tumors (GIST) depending on the molecular expression of tyrosine kinase receptor KIT (CD117). GISTs re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2afd41fd079502f7fa5c58295c6f4e7
https://doi.org/10.21037/jgo.2016.06.03
https://doi.org/10.21037/jgo.2016.06.03
Autor:
Miguel Angel Pluma, Samuel Rivera Rivera, Abdel Karim Dip Borunda, Gloria Martinez Martinez, Miguel Quintana, Alberto Pimentel, Juan Alejandro Silva, Luis Jonathan Bueno Rosario
Publikováno v:
Journal of Clinical Oncology. 36:514-514
514 Background: Gastroenteropancreatic neuroendocrine tumors (GEP NET´s) are infrequent tumors, with a variety of symptoms depending of the kind of peptide they secrete as well as the affected organs. Long acting somatostatin analogues have shown an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7df86300b2190f0eea0528fc8a6740b9
https://doi.org/10.1200/jco.2018.36.4_suppl.514
https://doi.org/10.1200/jco.2018.36.4_suppl.514
Publikováno v:
Journal of Clinical Oncology. 33:224-224
224 Background: Stromal tumors of the digestive tract are uncommon malignant diseases, and are subclassified as leiomyosarcomas and gastrointestinal stromal tumors (GIST) depending on the molecular expression of CD117 (KIT). GISTs represent 1% of mal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22a7edf33585aeaf4fb80db5ef3a58e4
https://doi.org/10.1200/jco.2015.33.3_suppl.224
https://doi.org/10.1200/jco.2015.33.3_suppl.224
Publikováno v:
Journal of Clinical Oncology. 30:e15567-e15567
e15567 Background: Primary debulking surgery is considered the standard of treatment in advanced ovarian cancer (AOC) while neoadjuvant chemotherapy is used in non resectable stages. Methods: We retrospectively analyzed 68 AOC cases from January 2000
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f592ad4ceb0aefef13f48ccadf6894ff
https://doi.org/10.1200/jco.2012.30.15_suppl.e15567
https://doi.org/10.1200/jco.2012.30.15_suppl.e15567
Autor:
María Guadalupe Villa Grajeda, Andrés de Jesús Morán Mendoza, Carlos Alberto Ronquillo Carreón, Abdel Karim Dip Borunda
Publikováno v:
Gaceta Mexicana de Oncología. (3):141-149
ResumenLos tumores neuroendocrinos son poco frecuentes, pero su incidencia está aumentando gradualmente. En el presente estudio se evaluaron las características demográficas y tumorales, el tipo de tratamiento, las tasas de respuesta y la superviv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d825581ed03f8247d1c6e44586d94f9f
Autor:
Svetlana V Doubova, Adriana Monroy, Saúl Eduardo Contreras Sánchez, Rocío Grajales Álvarez, Wendy Jazmín Martínez Pineda, Jose Gustavo Nuñez Cerrillo, Rita Zalapa Velázquez, Ingrid Patricia Martinez Vega, Ricardo Villalobos Valencia, Abdel Karim Dip Borunda, Lorena Lio Mondragón, Alma Diana Huerta López, Valeria Mendoza Ortiz, Víctor Javier Vázquez Zamora, Álvaro José Montiel Jarquín, Arturo García Galicia, Enrique Isay Talamantes Gómez, Roberto Sánchez Reyes, Jaqueline Aguirre Gómez, María Eugenia Ayala Anzures, Marta Zapata Tarrés, Hannah H. Leslie
Publikováno v:
BMJ Open, Vol 14, Iss 6 (2024)
Objectives This study aimed to explore the acceptability, feasibility, usability, and preliminary effect of an electronic patient-reported outcome (ePRO) intervention for patients with breast cancer in Mexico.Design We conducted a multimethod non-ran
Externí odkaz:
https://doaj.org/article/1ba1ef4b07a543d085e7327608fb27b3